Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- Eko Devices, Inc.
- Study ID
- NCT05873387
- Status
- Recruiting
Conditions
- Pulmonary Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Use of Eko DUO stethoscope (paired ECG/PCG) — DEVICEAuscultation of heart sounds using electronic stethoscope
Study Details
The major goal of the study is to determine whether phonocardiography (using the Eko DUO stethoscope which can capture a three lead ECG reading) can present features that relate to the presence of PH diagnosed by echocardiography or right heart catheterization (RHC), and therefore have a potential to assist the provider to suspect PH.
Key Dates
- Start date
- Jul 12, 2023
- Status verified
- Jun 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 2,420 participants (estimated)
Arms
- Arm: Echocardiography ground-truthSubjects with ECG/PCG recordings labeled against echocardiography
- Arm: Right heart catheterization ground-truthSubjects with ECG/PCG recordings labeled against right heart catheterization
Primary Outcome Measure
Build a database of matched ECG/PCG recordings labeled against RHCs and echocardiograms [ Time Frame: Up to 2 years to complete database ]
Central Contacts
- Spencer Kieu714-623-6652
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Providence VA Medical Center | Providence | Rhode Island | 02908 | |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | Kelly Franchetti |
| The Miriam Hospital | Providence | Rhode Island | 02906 | Lori-Ann Desimone Guarav Choudhary, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Providence, RI
Related Studies
- Pulmonary Hypertension Association RegistryRecruiting · Pulmonary Hypertension Association, Inc. · Phoenix, Arizona
- Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PHPHASE2 · Recruiting · VA Office of Research and Development · Aurora, Colorado
- LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFPHASE3 · Recruiting · Tenax Therapeutics, Inc. · Tucson, Arizona
- A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489PHASE2 · Recruiting · Pfizer · Sacramento, California